Dr Sangeeta Kumari (Ph.D)

Dr. Sangeeta Kumari (Ph.D) has a diverse work experience in the field of scientific research. Dr Sangeeta is currently working as a Scientist at Arcturus Therapeutics, a position they started in June 2022. Prior to this, they worked as a Scientist at Oculogenex from January 2022 to May 2022.

Dr. Kumari also has experience as a Postdoctoral Researcher, having worked at the University of the Sciences in Philadelphia from June 2020 to January 2022. In this role, they conducted postdoctoral research and presented findings regularly to the research group.

Before that, they held a similar role as a Postdoctoral Researcher at Waterford Institute of Technology from June 2016 to May 2018. During this time, they conducted laboratory research, researched relevant literature, and reported findings to the research group.

In addition, Dr. Kumari worked as a Postdoctoral Researcher at Sungkyunkwan University from August 2014 to September 2015. In this role, they focused on the synthesis and application of non-viral RNA delivery carriers for cancer therapeutics.

Overall, Dr. Sangeeta Kumari's work experience showcases their expertise in scientific research, particularly in the areas of RNA delivery and cancer therapeutics.

Dr. Sangeeta Kumari (Ph.D) pursued their education in Chemistry. From 2009 to 2014, they attended CSIR-NATIONAL CHEMICAL LABORATORY and obtained their Ph.D degree in Chemistry. In 2019, Dr. Kumari furthered their knowledge by enrolling in a Certification in CRISPR gene editing course at Harvard University.